COVID-19: Vaccine Development at Full Tilt
Will the rapid development of COVID-19 vaccines lead to unsafe therapies?
Sheila Rocchio | | Opinion
With three promising vaccine candidates – and even approval of one in the UK – it appears that we are finally on the brink of a major breakthrough in the fight against COVID-19.
But the rapid development of vaccine candidates has raised concern as well as jubilation. Suddenly, a question that most people never gave much thought to is being discussed everywhere – just how do researchers and regulators know that a new therapy is safe and effective?
It’s an excellent question. After all, conventional wisdom conflates speed with hubris, so how safe can any therapy be that’s been “rushed” to market? I think this is best answered by flipping the question: why do drugs normally take so long to get to market?
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine